Association of the top 20 Alzheimer's disease risk genes with [<sup>18</sup>F]flortaucipir PET
Eddie Stage, Shannon L. Risacher, Kathleen A. Lane, Sujuan Gao, Kwangsik Nho, Andrew J. Saykin, Liana G. Apostolova, for the Alzheimer's Disease Neuroimaging Initiative
Abstract
Abstract Introduction We previously reported genetic associations of the top Alzheimer's disease (AD) risk alleles with amyloid deposition and neurodegeneration. Here, we report the association of these variants with [ 18 F]flortaucipir standardized uptake value ratio (SUVR). Methods We analyzed the [ 18 F]flortaucipir scans of 352 cognitively normal (CN), 160 mild cognitive impairment (MCI), and 54 dementia (DEM) participants from Alzheimer's Disease Neuroimaging Initiative (ADNI)2 and 3. We ran step‐wise regression with log‐transformed [ 18 F]flortaucipir meta—region of interest SUVR as the outcome measure and genetic variants, age, sex, and apolipoprotein E ( APOE ) ε4 as predictors. The results were visualized using parametric mapping at familywise error cluster‐level–corrected P < .05. Results APOE ε4 showed significant ( P < .05) associations with tau deposition across all disease stages. Other significantly associated genes include variants in ABCA7 in CN, CR1 in MCI, BIN1 and CASS4 in MCI and dementia participants. Discussion We found significant associations to tau deposition for ABCA7 , BIN1 , CASS4 , and CR1 , in addition to APOE ε4. These four variants have been previously associated with tau metabolism through model systems.